What is the share price of Pfizer Ltd (PFIZER) today?
The share price of PFIZER as on 1st October 2026 is ₹3858.90. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Pfizer Ltd (PFIZER) share?
The past returns of Pfizer Ltd (PFIZER) share are- Past 1 week: -4.14%
- Past 1 month: -17.29%
- Past 3 months: -13.78%
- Past 6 months: -20.52%
- Past 1 year: -25.12%
- Past 3 years: -0.07%
- Past 5 years: -30.75%
What are the peers or stocks similar to Pfizer Ltd (PFIZER)?
The peers or stocks similar to Pfizer Ltd (PFIZER) include:What is the dividend yield % of Pfizer Ltd (PFIZER) share?
The current dividend yield of Pfizer Ltd (PFIZER) is 1.94.What is the market cap of Pfizer Ltd (PFIZER) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Pfizer Ltd (PFIZER) is ₹17653.59 Cr as of 1st October 2026.What is the 52 week high and low of Pfizer Ltd (PFIZER) share?
The 52-week high of Pfizer Ltd (PFIZER) is ₹5578.50 and the 52-week low is ₹3792.10.What is the PE and PB ratio of Pfizer Ltd (PFIZER) stock?
The P/E (price-to-earnings) ratio of Pfizer Ltd (PFIZER) is 24.44. The P/B (price-to-book) ratio is 4.20.Which sector does Pfizer Ltd (PFIZER) belong to?
Pfizer Ltd (PFIZER) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Pfizer Ltd (PFIZER) shares?
You can directly buy Pfizer Ltd (PFIZER) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Pfizer Ltd
PFIZER Share Price
NSE₹3,858.900.42% (-16.10)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
PFIZER Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
PFIZER Performance & Key Metrics
PFIZER Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 24.01 | 4.20 | 1.94% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 45.78 | 5.74 | 0.50% |
75%
Analysts have suggested that investors can buy this stock
from 4 analysts
Price Upside
Earnings Growth
Rev. Growth
PFIZER Company Profile
Pfizer Limited is a pharmaceutical company. The Company has a portfolio of approximately 140 products across over 15 therapeutic areas.
SUNPHARMA
PE Ratio
37.64
37.64
1Y Return
10.32%
10.32%
Buy Reco %
93.33
93.33
TORNTPHARM
PE Ratio
83.82
83.82
1Y Return
33.92%
33.92%
Buy Reco %
81.48
81.48
ZYDUSLIFE
PE Ratio
22.68
22.68
1Y Return
15.23%
15.23%
Buy Reco %
55.56
55.56
CIPLA
PE Ratio
27.99
27.99
1Y Return
11.22%
11.22%
Buy Reco %
62.86
62.86
LAURUSLABS
PE Ratio
120.61
120.61
1Y Return
126.74%
126.74%
Buy Reco %
58.33
58.33
PFIZER Forecast
PFIZER Forecasts
Price
Revenue
Earnings
PFIZER Share Price Forecast
PFIZER Share Price Forecast
2026
Current
₹3,857.00
Baseline
Forecast for Oct 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹3,857.00
Baseline
Forecast for Oct 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
PFIZER Company Revenue Forecast
PFIZER Company Revenue Forecast
2026
Current
₹2.71
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2026
Current
₹2.71
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
PFIZER Stock EPS (Earnings Per Share) Forecast
PFIZER Stock EPS (Earnings Per Share) Forecast
2026
Current
₹157.91
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹157.91
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
PFIZER
PFIZER
Income
Balance Sheet
Cash Flow
Quarterly Normal View
PFIZER Income Statement
PFIZER Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 621.76 | 604.70 | 631.66 | 580.75 | 809.30 | 670.22 | 684.19 | 683.24 | 678.99 | 698.01 | ||||||||||
Operating & Other expenses | 357.20 | 385.37 | 399.34 | 392.00 | 364.41 | 393.03 | 412.41 | 475.04 | 393.28 | 405.61 | ||||||||||
EBITDA | 264.56 | 219.33 | 232.32 | 188.75 | 444.89 | 277.19 | 271.78 | 208.20 | 285.71 | 292.40 | ||||||||||
| Depreciation/Amortization | 13.75 | 14.60 | 14.99 | 14.80 | 16.40 | 14.41 | 14.28 | 14.26 | 14.78 | 14.26 | ||||||||||
| PBIT | 250.81 | 204.73 | 217.33 | 173.95 | 428.49 | 262.78 | 257.50 | 193.94 | 270.93 | 278.14 | ||||||||||
| Interest & Other Items | 6.95 | 2.11 | 2.10 | 1.51 | 2.69 | 3.25 | 2.13 | 1.99 | 2.11 | 1.46 | ||||||||||
| PBT | 243.86 | 202.62 | 215.23 | 172.44 | 425.80 | 259.53 | 255.37 | 191.95 | 268.82 | 276.68 | ||||||||||
| Taxes & Other Items | 65.00 | 51.91 | 56.88 | 44.84 | 94.86 | 67.78 | 66.35 | 50.11 | 69.00 | 72.21 | ||||||||||
| Net Income | 178.86 | 150.71 | 158.35 | 127.60 | 330.94 | 191.75 | 189.02 | 141.84 | 199.82 | 204.47 | ||||||||||
| EPS | 39.09 | 32.94 | 34.61 | 27.89 | 72.34 | 41.91 | 41.32 | 31.01 | 43.68 | 44.69 |
PFIZER Company Updates
PFIZER Stock Peers
PFIZER Past Performance & Peer Comparison
PFIZER Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Pfizer Ltd | 24.44 | 4.20 | 1.94% |
| Sun Pharmaceutical Industries Ltd | 37.64 | 5.15 | 0.89% |
| Torrent Pharmaceuticals Ltd | 83.82 | 10.31 | 0.71% |
| Zydus Lifesciences Ltd | 22.68 | 3.86 | 0.09% |
PFIZER Stock Price Comparison
Compare PFIZER with any stock or ETFCompare PFIZER with any stock or ETF
PFIZER
PFIZER Holdings
PFIZER Shareholdings
PFIZER Promoter Holdings Trend
PFIZER Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
PFIZER Institutional Holdings Trend
PFIZER Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Decreased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has decreased by 1.16%
PFIZER Shareholding Pattern
PFIZER Shareholding Pattern
PFIZER Shareholding History
PFIZER Shareholding History
Foreign Institutions
Mutual Funds Invested in PFIZER
Mutual Funds Invested in PFIZER
No mutual funds holding trends are available
Top 5 Mutual Funds holding Pfizer Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 4.3138% | Percentage of the fund’s portfolio invested in the stock 2.14% | Change in the portfolio weight of the stock over the last 3 months 0.90% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 69/131 (+2) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 3.2004% | Percentage of the fund’s portfolio invested in the stock 0.68% | Change in the portfolio weight of the stock over the last 3 months 0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 83/271 (+53) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.9472% | Percentage of the fund’s portfolio invested in the stock 1.70% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 44/163 (+1) |
Compare 3-month MF holding change on Screener
smallcases containing PFIZER stock
smallcases containing PFIZER stock
Looks like this stock is not in any smallcase yet.
PFIZER Events
PFIZER Events
PFIZER Dividend Trend
No Trend In Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
PFIZER has shown inconsistent dividend trend over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 1.94%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹19.44 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
PFIZER Dividend Trend
No Trend In Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
PFIZER has shown inconsistent dividend trend over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 1.94%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹19.44 every year
PFIZER Upcoming Dividends
PFIZER Upcoming Dividends
No upcoming dividends are available
PFIZER Past Dividends
PFIZER Past Dividends
Cash Dividend
Ex DateEx DateJul 17, 2026
Final
Final | Div/Share: ₹75.00
Dividend/Share
₹75.00
Ex DateEx Date
Jul 17, 2026
Cash Dividend
Ex DateEx DateJul 9, 2025
Special
Special | Div/Share: ₹30.00
Dividend/Share
₹30.00
Ex DateEx Date
Jul 9, 2025
Cash Dividend
Ex DateEx DateJul 9, 2025
Final
Final | Div/Share: ₹35.00
Dividend/Share
₹35.00
Ex DateEx Date
Jul 9, 2025
Cash Dividend
Ex DateEx DateAug 21, 2024
Final
Final | Div/Share: ₹35.00
Dividend/Share
₹35.00
Ex DateEx Date
Aug 21, 2024
Cash Dividend
Ex DateEx DateAug 11, 2023
Final
Final | Div/Share: ₹35.00
Dividend/Share
₹35.00
Ex DateEx Date
Aug 11, 2023
PFIZER Stock News & Opinions
PFIZER Stock News & Opinions
Articles & Videos
Corporate
Corporate
Pfizer Limited halts share trading ahead of financial results release in late 2026Pfizer Limited informed the Bombay Stock Exchange and the National Stock Exchange of India that the trading window for dealing in shares of the company will be closed from September 30, 2026, until 48 hours after the unaudited financial results for the half year ending September 30, 2026, are made public.
5 days agoCapital Market - Live
Corporate
Corporate
Sharad Goswami resigns from Pfizer Limited, effective September 25, 2026Pfizer Limited announced that Mr. Sharad Goswami, Senior Director – Policy & Public Affairs, has resigned from the company effective September 25, 2026, to pursue opportunities outside Pfizer Limited, as disclosed to the Bombay Stock Exchange and the National Stock Exchange of India.
2 weeks agoCapital Market - Live
Spotlight
Spotlight
Volumes jump at Pfizer Ltd counterPCBL Chemical Ltd, Jubilant Pharmova Ltd, Piramal Pharma Ltd, OneSource Specialty Pharma Ltd are among the other stocks to see a surge in volumes on NSE today, 08 September 2026.Pfizer Ltd witnessed volume of 1.42 lakh shares by 14:24 IST on NSE, a 7.67 times surge over two-week average daily volume of 18557 shares. The stock dropped 5.73% to Rs.4,333.00. Volumes stood at 17548 shares in the last session.PCBL Chemical Ltd witnessed volume of 50.95 lakh shares by 14:24 IST on NSE, a 7.15 times surge over two-week average daily volume of 7.13 lakh shares. The stock increased 2.41% to Rs.325.10. Volumes stood at 11.25 lakh shares in the last session.Jubilant Pharmova Ltd witnessed volume of 12.33 lakh shares by 14:24 IST on NSE, a 5.93 times surge over two-week average daily volume of 2.08 lakh shares. The stock increased 4.64% to Rs.994.40. Volumes stood at 3.17 lakh shares in the last session.Piramal Pharma Ltd clocked volume of 196.28 lakh shares by 14:24 IST on NSE, a 5.31 times surge over two-week average daily volume of 36.93 lakh shares. The stock gained 2.69% to Rs.225.57. Volumes stood at 64.07 lakh shares in the last session.OneSource Specialty Pharma Ltd recorded volume of 6.53 lakh shares by 14:24 IST on NSE, a 5.09 times surge over two-week average daily volume of 1.28 lakh shares. The stock gained 1.27% to Rs.1,572.00. Volumes stood at 1.4 lakh shares in the last session.
3 weeks agoCapital Market - Live
Corporate
Corporate
Pfizer Limited will cease Minipress XL sales by 2026, receiving $13.9 millionPfizer Limited announced that it will discontinue the marketing, distribution, and sale of Minipress XL effective September 7, 2026, following a decision by Pfizer Inc. USA to discontinue the manufacture of the drug, and will receive a lump sum payment of USD 13.9 million, equivalent to Rs 131.38 crore, from Pfizer Inc. USA.
3 weeks agoCapital Market - Live
Earnings
Earnings
Pfizer standalone net profit rises 6.63% in the June 2026 quarterNet profit of Pfizer rose 6.63% to Rs 204.47 crore in the quarter ended June 2026 as against Rs 191.75 crore during the previous quarter ended June 2025. Sales rose 8.31% to Rs 653.17 crore in the quarter ended June 2026 as against Rs 603.05 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales653.17603.05 8 OPM %37.9034.83 - PBDT290.94273.94 6 PBT276.68259.53 7 NP204.47191.75 7 Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Corporate
Pfizer to hold board meetingPfizer will hold a meeting of the Board of Directors of the Company on 28 July 2026.
2 months agoCapital Market - Live
Corporate
Corporate
Board of Pfizer recommends final dividendPfizer announced that the Board of Directors of the Company at its meeting held on 12 May 2026, inter alia, have recommended the final dividend of Rs 75 per equity Share (i.e. 750%) , subject to the approval of the shareholders.
4 months agoCapital Market - Live
Corporate
Corporate
Pfizer AGM scheduledPfizer announced that the 75th Annual General Meeting(AGM) of the company will be held on 28 July 2026.
4 months agoCapital Market - Live
Earnings
Earnings
Pfizer standalone net profit declines 39.62% in the March 2026 quarterNet profit of Pfizer declined 39.62% to Rs 199.82 crore in the quarter ended March 2026 as against Rs 330.94 crore during the previous quarter ended March 2025. Sales rose 6.31% to Rs 629.23 crore in the quarter ended March 2026 as against Rs 591.91 crore during the previous quarter ended March 2025. For the full year,net profit declined 5.88% to Rs 722.43 crore in the year ended March 2026 as against Rs 767.60 crore during the previous year ended March 2025. Sales rose 10.45% to Rs 2519.65 crore in the year ended March 2026 as against Rs 2281.35 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales629.23591.91 6 2519.652281.35 10 OPM %37.5038.43 -35.8832.45 - PBDT274.56269.39 2 1082.56904.07 20 PBT259.78252.99 3 1024.83843.28 22 NP199.82330.94 -40 722.43767.60 -6 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Corporate
Pfizer announces board meeting datePfizer will hold a meeting of the Board of Directors of the Company on 12 May 2026.
4 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 3.14%, vs industry avg of 11.75%
Over the last 5 years, market share decreased from 0.8% to 0.53%
Over the last 5 years, net income has grown at a yearly rate of 7.74%, vs industry avg of 10.44%